Official Title: A Phase Ib/II, Open-label, Multicenter Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma
AEB071 is an inhibitor of protein kinase C, which suppresses growth of uveal melanoma cells carrying GNAQ mutation. Quite an interesting combination.
Uh, I can't figure out this yahoo posting stuff. If u want to know why the stock is moving today other than possible reversal of oversold condition, check out Sally Church blog about 520 and boi markers on twitter. Best free scientific mind analysis you can get on a biotech tech stock.